Shanghai Huaxin Biotechnology

Shanghai Huaxin Biotechnology is a Chinese biopharmaceutical company specializing in the development, production, and commercialization of recombinant protein therapeutics. Founded in 1993 and currently operating as a subsidiary of Fosun Pharma, the company is a pioneer in China's genetic engineering industry. Its core product portfolio includes interferon alpha-2b (Sinfon), interferon alpha-2a (Sintofon), and recombinant human interleukin-2 (Sintecan). These therapies are widely utilized in the treatment of viral infectious diseases, such as Hepatitis B and C, as well as various oncological and dermatological conditions. The company maintains high-standard GMP-certified manufacturing facilities in Shanghai to support its large-scale biologics production.